An expert reviews risk factors and prevention strategies specific to women
New insights into shared inflammatory pathways and immune responses
Alzheimer’s, Lewy body and other etiologies have distinct presentations and treatments
TNFRSF1B gene variant associated with slower progression, offering potential drug target
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
An update on biomarkers and various therapies in development
New clinical trials size up an immunomodulator’s pleiotropic effects
Interdisciplinary research aims to glean insights for therapeutic translation
A review of the evidence
Cleveland Clinic IND application is first approved in Parkinson’s and Alzheimer’s